Skip to content

Filip Rybakowski

7 papers in the library · 4 citations · publishing 2022-2026

Papers

Sort Most recent Most cited

Multimodal predictors of response to intravenous ketamine in treatment-resistant depression: toward personalized treatment in major depressive and bipolar disorders.

CNS Spectrums September 28, 2026 Magda Malewska-Kasprzak, Filip Rybakowski, Monika Dmitrzak-Weglarz

Intravenous ketamine is a rapid-acting intervention for treatment-resistant depression (TRD) in adults with major depressive disorder and bipolar disorder (BD). While efficacy is established, a comprehensive integration of clinical, neurophysiological, biomarker, metabolic, and cognitive predictors remains lacking, limiting precision CNS-targeted therapy. To synthesize recent evidence on...

Predictors of the Effectiveness of Psychedelics in Treating Depression—A Scoping Review

International Journal of Molecular Sciences February 26, 2026 James Chmiel, Filip Rybakowski

Psychedelic-assisted therapies (PATs) can produce rapid and sustained antidepressant effects, yet variability in response remains substantial. Identifying predictors and moderators is essential for optimising patient selection, preparation, and delivery. To map and synthesise the evidence on the predictors of antidepressant response to classic/serotonergic psychedelics administered with...

DOI: 10.3390/ijms27052202 (opens in new tab) Comorbidity Antidepressant Psycinfo Medline +5

Neurobiological correlates of treatment-resistant depression: implications for pharmacotherapy

Neuropsychiatria i Neuropsychologia 2026 Joanna Kot, Ewa Ferensztajn-Rochowiak, Oryna Kaliuzhna et al.

Treatment-resistant depression (TRD) affects about 30% of patients with major depressive disorder and remains a major clinical challenge.The limited effectiveness of classical antidepressants suggests that the pathophysiology of TRD is complex and extends beyond the traditional monoamine hypothesis.The aim of this paper was to present current concepts of the neurobiological background of TRD...

DOI: 10.5114/nan.2026.162406 (opens in new tab) Pharmacotherapy Medline Disease Drug +1

Mindfulness-Based Art Therapy with Hospitalized Depressed Individuals–The Temporal Order of Change in Mindfulness, Rumination, and Affect

Journal of Happiness Studies August 1, 2025 Maja Stańko-kaczmarek, Tomasz Jankowski, Robert Bartel et al.

Abstract Mindfulness-based art therapy (MBAT) is an interdisciplinary intervention that integrates mindfulness techniques with art activities. While previous research has examined MBAT’s effectiveness in reducing depressive symptoms, little is known about the temporal dynamics of change during participation. This study explored session-to-session changes in mindfulness, rumination, and affect...

The evolutionary and neurobiological attributes of consciousness: an update.

Psychiatria Polska June 30, 2024 Janusz Rybakowski, Filip Rybakowski

Consciousness is most frequently defined as a subjective experience of mental processes. The phenomenon of consciousness has always been a subject of great interest in various fields of science, including psychiatry, and the most prominent scientists have engaged in research on it. The studies performed in recent years have brought about novel data on the evolutionary and neurobiological...

DOI: 10.12740/PP/174391 (opens in new tab) Full text (opens in new tab) Evolution of consciousness Neurobiology of consciousness

The Effectiveness of Mindfulness in the Treatment of Methamphetamine Addiction Symptoms: Does Neuroplasticity Play a Role?

Brain Sciences March 27, 2024 James Chmiel, Agnieszka Malinowska, Filip Rybakowski et al. 4 citations

Methamphetamine is a highly stimulating psychoactive drug that causes life-threatening addictions and affects millions of people around the world. Its effects on the brain are complex and include disturbances in the neurotransmitter systems and neurotoxicity. There are several known treatment methods, but their effectiveness is moderate. It must be emphasised that no drugs have been approved...

Changes in adipokine concentrations in antidepressant-resistant bipolar depression after ketamine infusion and electroconvulsive therapy

The World Journal of Biological Psychiatry July 4, 2022 Monika Dmitrzak-Weglarz, M. Tyszkiewicz-Nwafor, Filip Rybakowski et al.

Abstract Objectives This study attempts to assess the concentration of two opposite-acting adipokines (anti-inflammatory adiponectin and pro-inflammatory resistin) in antidepressant-resistant patients undergoing ketamine infusion (KI) and electroconvulsive therapy (ECT). Methods The study group comprised 52 patients hospitalised due to episodes of depression in the course of bipolar disorders....